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Purinergic Receptors Are Part of a Signaling System for
Keratinocyte Proliferation, Di¡erentiation, and Apoptosis
in Human Fetal Epidermis
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We have investigated the expression of P2X5, P2X7,
P2Y1, and P2Y2 receptor subtypes in 8- to 11-wk-old
human fetal epidermis in relation to markers of pro-
liferation (proliferating cell nuclear antigen (PCNA)
and Ki-67), keratinocyte di¡erentiation (cytokeratin
K10 and involucrin), and markers of apoptosis (TdT-
mediated dUTP nick end labeling (TUNEL) and anti-
caspase-3). Immunohistochemistry showed that each of
the four receptors was expressed in spatially distinct
zones of the developing epidermis: P2Y1 receptors were
found in the basal layer, P2X5 receptors were predomi-
nantly in the basal and intermediate layers, and both
P2Y2 and P2X7 receptors were in the periderm. Colo-
calization experiments suggested di¡erent functional
roles for these receptors. P2Y1 receptors were found in
fetal keratinocytes positive for PCNA and Ki-67, sug-
gesting a role in proliferation. P2X5 receptors double la-
beled with di¡erentiated fetal keratinocytes that were
positive for cytokeratin K10, suggesting a role in di¡er-
entiation. P2X7 receptors colocalized with anti-caspase-
3 antibody and were also expressed in periderm cells
positive for TUNEL, suggesting a role in periderm cell
apoptosis. P2Y2 receptors were found only in periderm
cells and may have a role in chloride and £uid secretion
into the amniotic £uid. Key words: apoptosis cell di¡eren-
tiation/proliferation receptors/periderm/purinergic P2. J Invest
Dermatol 121:1145 ^1149, 2003
A
denosine 50 -triphosphate (ATP) is now recognized
as an important messenger molecule for cell^cell
communication, with ATP binding speci¢cally to
purinergic receptors (Ralevic and Burnstock, 1998).
There is increasing evidence that purinergic signal-
ing can have long-term, trophic e¡ects in embryonic develop-
ment, cell proliferation, di¡erentiation, and death (Abbracchio
and Burnstock, 1998; Burnstock, 2001).
Purinergic receptors are classi¢ed into two groups: P1 receptors
are selective for adenosine and P2 receptors are selective for ATP
and adenosine 50 -diphosphate, which act as extracellular signal-
ing molecules (Burnstock, 1978). P2 receptors are divided into
two main families: P2X (ligand-gated ion channels) and P2Y
(G-protein-coupled receptors), based on molecular structure,
transduction mechanisms, and pharmacologic properties (Ab-
bracchio and Burnstock, 1994). Eight subtypes of P2Y receptors
have been described, and seven subtypes of P2X receptors are re-
cognized (Burnstock, 2003).
ATP is likely to be an important local messenger in the epider-
mis. Both P2X5 and P2X7 receptors are expressed on adult rat
cutaneous keratinocytes and functional roles in the regulation of
proliferation, di¡erentiation, and cell death have been proposed
(Gr˛schel-Stewart et al, 1999). P2Y2 receptors, found in the basal
layer of normal adult epidermis, are claimed to be involved in
keratinocyte proliferation (Dixon et al, 1999). Studies on adult hu-
man epidermis and primary keratinocyte cultures have suggested
that P2Y1 and P2Y2 receptors are involved in keratinocyte prolif-
eration, that P2X5 receptors are likely to be involved in keratino-
cyte di¡erentiation, and that P2X7 receptors are likely to be part
of the machinery of end stage terminal di¡erentiation/apoptosis
of keratinocytes (Greig et al, 2003).
Human fetal skin is unique in structure and function and is in
a continuum of change until birth. The transition from fetal to
mature epidermis of the neonate and adult involves formation of
new epidermal layers, invagination and remodeling of epidermal
appendages, and ¢nally loss of fetal-speci¢c cell types and onset
of adult-type di¡erentiation (see Holbrook and Ho¡, 1984, for a
review). The primitive epidermis is established at 7 to 8 d when
ectoderm and endoderm are de¢ned in the inner cell mass of the
implanted blastocyst. At this stage the epidermis is a single-
layered ‘‘indi¡erent ectoderm.’’A second epidermal layer forms at
the end of the fourth week.The outermost of the two layers is the
periderm. The periderm is the transient, protective covering of
the epidermis that is sloughed into the amniotic £uid as soon as
di¡erentiation of the underlying epidermal layers is complete at
20 to 24 wk. Beneath the periderm, basal keratinocytes comprise
the single layer of the ‘‘epidermis proper.’’At the end of the ninth
week, the embryonic^fetal transition, basal cells divide to give
rise to daughter cells that move vertically to form the ¢rst inter-
mediate cell layer that characterizes the fetal epidermis. Two or
three more layers of intermediate cells are added to the epidermis
in the second trimester (12^24 wk). Once a granular layer is
established in the sixth month, the intermediate cells become
known as spinous cells; thus each layer of the epidermis assumes
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the adult nomenclature as the tissue assumes the adult character-
istics.The ¢rst stratum corneum develops at the end of the second
trimester (24 wk), consisting of only a few cell layers, which in-
crease in thickness during the third trimester and, at birth, it is
approximately equivalent to that of the adult.
This study demonstrates the distribution of P2X and P2Y
receptors in human fetal epidermis.We propose that these receptors
are part of the normal mechanisms controlling fetal epidermal
development in relation to keratinocyte proliferation, di¡erentia-
tion, and apoptosis.
MATERIALS AND METHODS
Tissues Twenty-¢ve samples of normal human fetal skin were examined
from nine fetuses at 8 to 11 wk estimated gestational age, which was
determined by fetal measurements after pregnancy termination. Samples
were obtained from fully informed, consenting patients undergoing
elective terminations of pregnancy. Ethics Committee approval was
obtained to harvest human fetal samples. Tissue was frozen in isopentane
precooled in liquid nitrogen. Blocks were sectioned at 10 mm on a
cryostat (Reichert Jung CM1800), collected on gelatin-coated slides, and
air-dried at room temperature. The slides were stored at 201C.
Antibodies The immunogens used for production of polyclonal P2X5
and P2X7 antibodies were synthetic peptides corresponding to 15
receptor-type-speci¢c amino acids in the intracellular C-termini of the
cloned rat and human P2X receptors, as described previously (Gr˛schel-
Stewart et al, 1999; Oglesby et al, 1999). P2X5 and P2X7 antibodies
(provided by Roche Bioscience, Palo Alto, CA) were kept frozen at a
stock concentration of 1 mg per mL. Polyclonal anti-P2Y1 and P2Y2
antibodies were obtained from Alomone Laboratories (Jerusalem, Israel)
and corresponded to the third extracellular loop of the P2Y1 (amino acids
242^258) and P2Y2 receptor (amino acids 227^244). Antibodies were kept
frozen at a stock concentration of 0.6 mg per mL (P2Y1, P2Y2).
Proliferating cell nuclear antigen (PCNA) is a marker for proliferation
in normal adult human keratinocytes (Miyagawa et al, 1989). Cytokeratin
K10 and involucrin are markers for keratinocyte di¡erentiation (Eckert
et al, 1997). PCNA (monoclonal anti-PCNA, clone PC10, raised in
mouse ascites £uid; Sigma Chemical Co., Poole, UK), cytokeratin K10
(BioGenex, San Ramon, CA), and involucrin (Sigma Chemical Co.)
antibodies were raised in mouse. Ki-67 antigen is a marker for cell
proliferation in normal human keratinocytes (Tucci et al, 1998). Active
caspase-3 is part of the apoptotic machinery of the cell and is expressed in
terminally di¡erentiating keratinocytes (Weil et al, 1999). Ki-67 (Dako,
Denmark) and active caspase-3 (Abcam, Cambridge, UK) antibodies were
both raised in rabbit.
Immunohistochemistry: double-labeling techniques. Double label-
ing of P2X or P2Y receptor antibodies with PCNA, cytokeratin
K10, or involucrin For immunostaining of cryostat sections, the avidin^
biotin technique was used according to a revised protocol (Llewellyn-
Smith et al, 1992). Air-dried sections were ¢xed for 2 min in 4%
formaldehyde in 0.1 M phosphate bu¡er, containing 0.2% of a saturated
solution of picric acid (pH 7.4). Endogenous peroxidase was blocked for 10
min with 50% methanol containing 0.4% hydrogen peroxide. Nonspeci¢c
binding sites were blocked by a 20-min preincubation in 10% normal
horse serum in 0.1 M phosphate bu¡er, containing 0.05% merthiolate
(Sigma Chemical Co.), followed by incubation with the primary
antibodies diluted to 1:100 or 1:200 in antibody diluent (10% normal horse
serum in phosphate-bu¡ered saline (PBS)þ 2.5% sodium chloride at 41C
overnight.
After a wash step, biotinylated donkey anti-rabbit IgG antibody, diluted
1:500 in 1% normal horse serum in PBS, was then applied for 1 h followed
by streptavidin^Texas red (Amersham International plc., UK), diluted
1:200 in PBS^merthiolate for 1 h at room temperature. Sections were
preincubated for 30 min with 10% normal goat serum diluted in 0.1 M
phosphate bu¡er, containing 0.05% merthiolate (Sigma Chemical Co.).
They were then incubated for 2 h at room temperature with one of the
following antibodies: PCNA antibody (Sigma Chemical Co.) diluted
1:1000; mouse anti-human cytokeratin K10 (BioGenex) diluted 1:50;
mouse monoclonal anti-involucrin (Sigma Chemical Co.) diluted 1:50.
After a wash step, the directly labeled secondary antibody goat anti-mouse
FITC (Nordic Immunological Laboratories, Tilburg, the Netherlands) was
applied at a dilution of 1:200 for 1 h, and then sections were washed and
mounted in Citi£uor (Citi£uor Ltd, Leicester, UK). P2X or P2Y receptor
immunostaining appeared red and PCNA, cytokeratin K10, and involucrin
stained green.
Double-labeling of P2X or P2Y receptor antibodies with either Ki-
67 antigen or antihuman caspase-3 Sections were ¢xed and incubated
with P2X or P2Y antibodies overnight, as described above. After being
washed, sections were incubated with biotinylated donkey anti-rabbit IgG
(Jackson ImmunoResearch Laboratory) diluted to 1:500 in 1% normal
horse serum in PBS for 1 h, followed by ExtrAvidin peroxidase conjugate
(Sigma Chemical Co.) diluted to 1:1500 in PBS for 1 h, tyramide
ampli¢cation for 8 min (tyramide ampli¢cation kit, NEN Life Science
Products, Boston, MA) and then streptavidin^Texas red (Amersham
International plc.), diluted 1:200 in PBS^merthiolate for 10 min. Sections
were washed three times in PBS after each of the above steps. Sections
were preincubated for 20 min in 10% normal goat serum and then
incubated at room temperature for 2 h with one of the following
antibodies: rabbit anti-human Ki-67 antigen (Dako) 1:50 or rabbit anti-
human active caspase-3 (Abcam). Sections were then washed and
incubated with the directly labeled secondary antibody Oregon-green-
labeled goat anti-rabbit IgG (Jackson ImmunoResearch Laboratory),
diluted 1:100 for 45 min. Sections were then washed and mounted in
Citi£uor (Citi£uor Ltd). P2X or P2Y receptor immunostaining appeared
red and Ki-67 and caspase-3 stained green.
Double labeling of P2X7 receptor antibodies with TdT-mediated
dUTP nick end labeling (TUNEL) TUNEL identi¢es cells under-
going apoptosis by labeling nuclear DNA fragments that have been
cleaved during apoptosis (Gavrieli et al, 1992). TUNEL labeling was
performed using a kit (Boehringer Mannheim, Germany). After
overnight incubation with P2X7 receptor antibody diluted to 1:200 as
above, sections were washed in PBS and then incubated with the TUNEL
reaction mixture for 1 h at 371C. As a negative control, sections were
incubated with the TUNEL solution only. After additional washes in
PBS, sections were incubated for 1 h with biotinylated donkey anti-rabbit
antibody at a concentration of 1:500. Sections were washed in PBS and then
incubated for 1 h with streptavidin^Texas red (Amersham International
plc.) at a concentration of 1:200. Sections were washed in PBS and
mounted in Citi£uor (Citi£uor Ltd). P2X7 receptor immunostaining
appeared red and TUNEL labeling was green.
Controls Control experiments were carried out with primary antibodies
omitted from the staining procedure or the primary antibodies pre-
absorbed with the corresponding peptides.
Photography The results were photographed using a Zeiss Axioplan,
high-de¢nition light microscope (Oberkochen, Germany) mounted with
a Leica DC 200 digital camera (Heerbrugg, Switzerland).
RESULTS
P2X5, P2X7, P2Y1, and P2Y2 receptor expression in human
fetal epidermis P2X5 and P2X7 receptor immunoreactivity
was observed in the epidermal keratinocytes of all human fetal
skin samples (Fig 1a,b). P2X5 receptor immunoreactivity was
found mainly in the basal layer and to a lesser extent in the
intermediate cell layer (Fig 1c). P2X5 receptors were found in
the cell membranes and sometimes in the cell cytoplasm, but
not in the nucleus. The P2X5 receptor staining on keratinocytes
in the stratum basale appeared to be polarized, being concentrated
on the basal aspects of cells associated with the basement
membrane (Fig 1c). In the epidermis, P2X7 receptor immuno-
reactivity was associated with periderm cells only (Fig 1d);
P2X7 receptor immunostaining also labeled fetal blood cells. P2Y1
receptors were found in the basal layer of the epidermis (Fig 1e)
and P2Y2 receptors were expressed only in the periderm
(Fig 1f).
Double labeling of P2Y1 and P2Y2 receptors with markers
for cellular proliferation Fetal skin was double-stained for
Ki-67 and P2Y1 receptors (Fig 1g) and PCNA and P2Y2 recep-
tors (Fig 1h). The proliferation markers identi¢ed a proliferating
subpopulation of basal keratinocytes. Cells positive for these two
markers were also positive for P2Y1 but not for P2Y2 receptors,
which were only found in periderm cells.
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Double labeling of P2X5 receptors with markers for
keratinocyte di¡erentiation Double labeling of P2X5
receptors with cytokeratin K10 (Fig 1i) showed that P2X5
receptors were expressed in di¡erentiating keratinocytes with-
in the fetal epidermis. Cytokeratin K10, an early marker of
keratinocyte di¡erentiation, was found in cells in the
intermediate cell layer and not in basal keratinocytes. The basal
layer stained only for P2X5 receptors, and not for markers of
di¡erentiation, indicating that no di¡erentiation was taking
place in these cells. Involucrin, a late marker of keratinocyte
di¡erentiation in adult skin, was expressed only in the periderm
cells and did not colocalize with P2X5 receptor staining (Fig 1j).
Double labeling of P2X7 receptors with markers for
apoptosis in fetal epidermis show colocalization Individual
rounded periderm cells had nuclei that stained strongly positive
for TUNEL (Fig 1k). This corresponded to a transitional stage
when the periderm is beginning the formation of a series of
complex surface blebs. Double staining of the P2X7 receptor
and TUNEL showed that only intermittent cells were positive
for TUNEL, although P2X7 receptors were expressed in most of
the cells in the periderm layer. The negative control for TUNEL
showed no reaction. Double labeling of P2X7 receptors with anti-
caspase-3 showed colocalization within the periderm (Fig 1l).
Controls Both the omission of the primary antibody and the
preabsorption with corresponding peptides were performed as
controls. The immunoreaction was abolished after preabsorption
of the P2X5, P2X7, P2Y1, or P2Y2 receptor antibodies with
the corresponding peptides, con¢rming the speci¢city of the
immunoreaction.
DISCUSSION
This study has shown the ¢rst direct evidence for the expression
of P2X5, P2X7, P2Y1, and P2Y2 receptors in 8- to 11-wk-old
Figure1. Expression of P2X5, P2X7, P2Y1,
and P2Y2 receptors in human fetal epider-
mis and double labeling with markers for
cellular proliferation, keratinocyte di¡er-
entiation, and markers for apoptosis. (a)
Cross-section of hand of 9-wk-old fetus show-
ing P2X5 receptor immunostaining. Bar, 375
mm. (b) Cross-section of hand of 9-wk-old fetus
show-ing P2X7 receptor immunostaining, with
a predominance on the dorsal surface (arrow).
Bar, 375 mm. (c) High-power view of (a): P2X5
receptor staining was mainly found in the basal
layer (B) of the epidermis and to a lesser extent
in the intermediate layer (I). There was little
staining in the periderm (P). Bar, 25 mm. (d)
High-power view of (b): P2X7 receptor immu-
noreactivity was associated with cells within the
periderm (P). Bar, 25 mm. (e) P2Y1 receptors
were found in the basal layer (B) of the epider-
mis. Bar, 25 mm. (f) P2Y2 receptors were found
in the periderm (P). Bar, 25 mm. (g) Double la-
beling of fetal epidermis with P2Y1 receptors
(red) and Ki-67 (green) to show that P2Y1 recep-
tors are found in proliferating cells in the basal
layer (B). Bar, 25 mm. (h) Double labeling of
P2Y2 receptors (red) and PCNA (green). PCNA
identi¢ed a proliferating subpopulation of only
basal keratinocytes (B), but P2Y2 receptors were
only found in periderm cells (P). Bar, 25 mm. (i)
Double labeling of P2X5 receptors (red) with
cytokeratin K10 (green). Cytokeratin K10 was
found in cells in the intermediate cell layer (I)
and not in basal keratinocytes (B). The stratum
basale (B) stained only for P2X5 receptors, indi-
cating that no di¡erentiation was taking place
in these cells. Bar, 25 mm. (j) Double labeling
of P2X5 receptors (red) with involucrin (green).
Involucrin was expressed only in the periderm
cells (P) and did not colocalize with P2X5 re-
ceptor staining in the basal (B) and intermediate
(I) layers. Bar, 25 mm. (k) Double labeling (yel-
low) of P2X7 receptors (red) with TUNEL
(green). Only intermittent, rounded periderm
cells (P) had nuclei that stained strongly posi-
tive for TUNEL although P2X7 receptors were
expressed in most of the cells in the periderm
layer. Bar, 25 mm. (l) Double labeling (yellow)
of P2X7 receptors (red) with anti-caspase-3
(green) showed colocalization within the peri-
derm (P). Bar, 25 mm.
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human fetal epidermis, using immunohistochemistry. Four peri-
ods of human epidermal development have been identi¢ed (Dale
et al, 1985). The ¢rst is the embryonic period (before 9 wk esti-
mated gestational age) and the others are within the fetal period:
strati¢cation (9^14 wk), follicular keratinization (14^24 wk), and
interfollicular keratinization (beginning approximately 24 wk).
We have studied epidermal tissue at the end of the embryonic
period and during the period of strati¢cation. It would be of in-
terest to have studied fetal tissue from di¡erent stages of gestation
but fresh-frozen tissue was not available for other time points.
Purinergic receptors bind ATP, which is found in all cells. In-
tracellular ATP can be released passively from dying, necrotic
cells undergoing cytolysis, or it can be actively released from liv-
ing cells by vesicular release or via ATP-binding cassette proteins
(Bodin and Burnstock, 2001). In our study, we have seen that pur-
inoceptors are distributed on cell membranes and in the cyto-
plasm. Internalization of purinoceptors has been observed in a
variety of circumstances including synthesis of receptors in the
cytoplasm and transport to the cell membrane (Loesch and Burn-
stock, 2001) and following prolonged exposure to ATP (Li et al,
2000).
P2Y1 receptors showed a strong immunopositive signal in the
basal layer of the fetal epidermis, which is known to be where
keratinocyte proliferation occurs (Bickenbach and Holbrook,
1987). Double labeling of P2Y1 receptors and keratinocyte prolif-
eration markers Ki-67 and PCNA was performed. This con-
¢rmed the presence of P2Y1 receptors in proliferating cells,
indicating that this receptor is involved in keratinocyte prolifera-
tion. The distribution of P2Y1 receptors was the same as in adult
epidermis (Greig et al, 2003).
P2X5 receptors were expressed in the basal layer of human fetal
epidermis and were also expressed in the intermediate cell layer,
where cytokeratin K10, an early marker of keratinocyte di¡eren-
tiation, was found. It is known that keratinocytes that initially
occupy the intermediate layer of fetal epidermis from 9 to 20
wk gestation undergo only an incomplete type of di¡erentiation
(Holbrook, 1991) that is not characteristic of the mature epider-
mis. Although not morphologically di¡erent, the intermediate
cells at this stage have initiated biochemical di¡erentiation, char-
acterized by the synthesis of epidermal di¡erentiation-speci¢c
markers, keratins 1 and 10 (Dale et al, 1985) as seen in our study.
The expression of these keratins is thought to herald the commit-
ment of the keratinocyte to a program of epidermal keratinocyte
di¡erentiation (Haake and Cooklis, 1997). Double labeling of
P2X5 receptors with cytokeratin K10 showed that P2X5 receptors
were expressed in di¡erentiating keratinocytes within the fetal
epidermis, so it seems likely that P2X5 receptors are involved in
fetal epidermal keratinocyte di¡erentiation. The basal layer
stained only for P2X5 receptors and not cytokeratin K10, indicat-
ing that basal cells were not di¡erentiated, so P2X5 receptors may
also have an additional role in basal keratinocytes. There is evi-
dence from other tissues regarding the role of P2X5 receptors. In
fetal rat skeletal muscle, P2X5 receptors are sequentially expressed
during development (Ryten et al, 2001). P2X5 receptors have been
implicated in the regulation of osteoblastic di¡erentiation and
proliferation (Hoebertz et al, 2000) and in triggering the di¡eren-
tiation of skeletal muscle satellite cells (Ryten et al, 2002).
Involucrin, a late marker of keratinocyte di¡erentiation in
adult skin and a corni¢ed cell envelope precursor protein, was
expressed only in periderm cells and did not colocalize with
P2X5 receptor staining. The lack of dual labeling might simply
be due to the incomplete nature of epidermal di¡erentiation at
this stage in development, because involucrin is a late marker of
di¡erentiation. Involucrin has previously been found to be ex-
pressed only on periderm cells in fetal epidermis at the same stage
of development (Akiyama et al, 1999) and is thought to be repre-
sentative of a process of keratinization within the periderm, sepa-
rate from the keratinization of the underlying ‘‘proper’’epidermal
layers that occurs later in development. In adult epidermis, we
found that involucrin colocalized with P2X5 receptors only in
the upper layers of the stratum spinosum (Greig et al, 2003).
Cells in the periderm were intensely stained for TUNEL and
caspase-3. Double staining of the P2X7 receptor and TUNEL
showed that only intermittent cells were positive for TUNEL,
although P2X7 receptors were expressed in most of the cells in
the periderm layer. Double labeling of P2X7 receptors with
anti-caspase-3 showed colocalization within the periderm. The
P2X7 receptor is unlike other P2X receptors because it is a
bifunctional molecule that can be triggered to act as a channel
permeable to small cations or on prolonged stimulation can form
a cytolytic pore permeable to large hydrophilic molecules of up
to 900 Da (Surprenant et al, 1996).The opening of this pore results
in the increase in intracellular cytosolic free calcium ions and the
induction of cell death and there is increasing evidence that this
process is dependent on the caspase signaling cascade (Ferrari et al,
1999). Caspase-3 is expressed in adult terminally di¡erentiating
keratinocytes (Weil et al, 1999). During apoptosis, the nucleus
condenses and DNA is fragmented by endonucleases, which can
be detected by TUNEL. TUNEL-positive keratinocytes have
been found in the upper regions of the granular layer of the adult
epidermis, before corni¢cation (Polakowska et al, 1994; Tamada
et al, 1994; Gandarillas et al, 1999). Nuclei of individual peri-
derm cells have been previously reported to stain positively for
TUNEL from about 14 wk estimated gestational age (Polakowska
et al, 1994). In this study, the periderm was shown to exhibit char-
acteristics consistent with apoptosis before its loss from the epi-
dermis, which occurs at midgestation (20^24 wk). The periderm
undergoes a series of morphologic changes that have been de-
scribed ultrastructurally including: blebbing of the cell surface
and pinching o¡ of cytoplasmic fragments, accumulation of cy-
toplasmic ¢laments, formation of a submembranous cell envel-
ope, and a pyknotic nucleus (Holbrook and Odland, 1975). These
morphologic changes in the periderm are similar to those de-
scribed for other cell types undergoing apoptosis (Kerr et al,
1972) and the time of their onset correlates with the appearance
of markers of apoptosis (Polakowska et al, 1994). Following the
bleb stage, periderm cells also exhibit a number of regressive
changes involving partial organelle degeneration and accumula-
tion of ¢laments in the cytoplasm. It is thought that apoptosis is
the mechanism by which periderm cells are deleted from the epi-
dermis after serving their function (Polakowska et al, 1994). In this
study, it is likely that periderm cells at 8 to 11wk estimated gesta-
tional age, which double label for P2X7 receptors and markers of
apoptosis, are showing a preliminary stage in the journey toward
apoptosis, because they do not have the characteristic histologic
appearance of apoptosis. The expression of P2X7 receptors may
be important in the regulation of apoptosis intrinsic to correct
development.
Interestingly, P2Y2 receptors were also found only in periderm
cells. In adult skin, P2Y2 receptors were found in the basal layer
of the epidermis, where proliferation markers Ki-67 and PCNA
were also found (Greig et al, 2003). The P2Y2 receptor agonist,
uridine 50 -triphosphate (UTP), caused a signi¢cant increase in
human keratinocyte cell number in vitro (Greig et al, 2003). Pre-
vious work has localized P2Y2 receptor mRNA in adult human
epidermal basal cells via in situ hybridization (Dixon et al, 1999).
UTP, the potent P2Y2 receptor agonist, has also been shown to
cause proliferation in keratinocytes (Dixon et al, 1999; Greig et al,
2003). Nevertheless, in fetal epidermis, P2Y2-receptor-positive
periderm cells were not positive for proliferation markers PCNA
and Ki-67.Therefore, P2Y2 receptors may have an alternative role
in periderm cells. For example, P2Y2 receptors on periderm cells
could be involved in chloride and £uid secretion into the amnio-
tic £uid. P2Y2 receptors are involved in ion and £uid secretion in
lung and conjunctival epithelial cells (Yerxa, 2001). Studies have
suggested that nonkeratinized fetal epidermis may have an
osmoregulatory function and also that the fetal epidermis contri-
butes to the formation of amniotic £uid in the ¢rst trimester and
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becomes the primary source in the second trimester (Holbrook,
1991). Periderm cells have microvilli and surface blebs that in-
crease the surface area of the plasma membrane exposed to the
amniotic £uid, there are large numbers of membrane-bound ve-
sicles adjacent to the plasma membrane, and tight junctions join
adjacent periderm cells. This suggests that the periderm cell layer
may have potential for £uid and ion transport (Holbrook, 1991).
In summary, P2 purinergic receptors are likely to be involved
in fetal keratinocyte proliferation via P2Y1 receptors found on ba-
sal cells and fetal keratinocyte di¡erentiation via activation of
P2X5 receptors. P2X7 receptors are likely to be involved in apop-
tosis of periderm cells, but the role of P2Y2 receptors in periderm
cells is currently unknown; it is suggested that they may play a
role in chloride and £uid secretion into the amniotic £uid.
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